Medscape Medical NewsAll articles

Sonio Suspect

Sonio • Radiology • 02/21/2025

510(k)IEC 62304 Class B
FDA Summary PDF

Device Purpose

Sonio Suspect is a machine learning-powered web application designed to assist healthcare professionals in identifying and characterizing abnormal findings in fetal ultrasound images. It leverages AI to automatically detect views and evaluate abnormalities, demonstrated through high sensitivity and specificity in standalone performance and improved diagnostic accuracy in clinical studies, supporting its safety and effectiveness as a concurrent reading aid.

Summary

Sonio Suspect is a software solution designed to assist healthcare professionals in identifying and characterizing abnormal findings during or after fetal ultrasound examinations. Utilizing machine learning techniques, this web-based application automatically detects fetal ultrasound views and evaluates specific abnormal findings on uploaded images, ranging from 11 to 41 weeks of gestational age. It serves as a concurrent reading aid, presenting statuses such as "Suspected," "Not Suspected," or "Can't be analyzed" for various fetal anatomical features and abnormalities, though it emphasizes that patient management decisions should not rely solely on its analysis.A review of Sonio Suspect concluded that the device is substantially equivalent to a legally marketed predicate device, allowing it to be marketed. This determination was supported by comprehensive performance data, including software verification and validation, and extensive testing. Standalone performance testing demonstrated high sensitivity (93.2%) and specificity (90.8%) in automatically detecting abnormal fetal ultrasound findings. Furthermore, a clinical study involving multiple readers showed a significant improvement in diagnostic accuracy when readers were assisted by Sonio Suspect, reinforcing its demonstrated safety and effectiveness.

AI Regulatory Concerns

Powered byJev by TypeSafe AI

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

Keywords

Sonio SuspectFetal ultrasoundMachine learningAbnormal findingsDiagnostic accuracyHealthcare professionalsConcurrent reading aidSensitivitySpecificityClinical study

Device Metadata

Submission Number
K243614
Company
Sonio
Panel
Radiology
Product Code
N/A
Data Type
N/A
Clinical Function
N/A
AI Function
N/A
AI Subclass
N/A

Relevant Clinical Questions

  • Q1. What specific machine learning algorithms does Sonio Suspect employ for fetal view detection and abnormality characterization?; How does the system's performance (sensitivity, specificity) vary across different gestational ages or types of fetal abnormalities?; What are the false positive and false negative rates of Sonio Suspect, and how might these impact clinical workflow or patient anxiety?; Are there plans for Sonio Suspect to integrate with EMR systems or provide direct recommendations for further diagnostic steps?; What kind of training is recommended for clinicians to optimally utilize Sonio Suspect and integrate its findings into their diagnostic process?

Risk Classification

ESL Analysis
FDA Device ClassII

FDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Post-§524B but no clear network capability detected

Learn how Parasoft automates IEC 62304 compliance testing →

Cybersecurity Evidence

Powered by SBOMator™

Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.

Cyber Score5/100
SBOM Evidence⚠ Not in summary - likely in full submission per §524B
Cyber Risk Assessment⚠ Not in summary - likely in full submission per §524B
Postmarket Plan⚠ Not in summary - likely in full submission per §524B
§524B ApplicableYes

Supply Chain BOM Evidence

Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.

SBOMSoftware Bill of Materials
- Not detected
ML-BOMMachine Learning Bill of Materials(machine learning, algorithm)
✓ Detected
SaaSBOMSoftware-as-a-Service Bill of Materials
- Not detected
HBOMHardware Bill of Materials
- Not detected
CBOMCryptography Bill of Materials
- Not detected
VDR/VEXVulnerability Disclosure Report / Vulnerability Exploitability eXchange
- Not detected
OBOMOperations Bill of Materials
- Not detected

Analysis:

• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.

• Evidence of ML-BOM detected in AI-generated device summary.

• SBOM not mentioned in AI-generated device summary. Under §524B (effective Oct 2023), cyber devices must provide a SBOM.

• Cybersecurity risk assessment not referenced in AI-generated device summary. FDA cybersecurity guidance (2023) expects this for cyber devices.

• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.

• Not detected in AI-generated device summary: SBOM, SaaSBOM, HBOM, CBOM, VDR/VEX, OBOM. These may be present in the full FDA submission.

Preparing a similar submission?

ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.

Assess Your Readiness →Or contact ESL directly
Sonio Suspect - Sonio | ESL FDA AI Device Intelligence